NL-OMON51328招募中不适用
Triple therapy convenience by the use of one or multiple inhaler and digital support in Chronic Obstructive Pulmonary Disease - TRICOLO
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Clinical diagnosis of COPD for at least 1 year before the screening visit
- •Aged 40 years and older
- •An indication for triple therapy according to the investigator*s judgement
- •(following the GOLD guideline 2021(2)).
- •Could be step-up from dual therapy or currently receiving triple therapy (both
- •MITT and SITT).
- •Owner of mobile device compatible with e-device app with access to internet
- •(Android or iOS)
- •Willing to provide written informed consent
- •Current or ex-smoker
排除标准
- •Inability to comply with study procedures or with study treatment
- •Inability to speak and/or read Dutch
- •Asthma as the predominant disease according to the investigator*s opinion, a
- •past history of asthma is allowed
- •Use of e-health application for COPD in the past six months
- •Patients with any other therapy that could interfere with the study drugs
- •(according to the investigator*s opinion)
- •Use of nebulized bronchodilators, for example via pari boy
- •Pregnant or lactating women and all women physiologically capable of becoming
- •pregnant unless they have highly effective contraceptive
- •Patients mentally or legally incapacitated, or patients accommodated in an
- •establishment as a result of an official or judicial order
- •Patients without the capability to complete the questionnaires
研究者
相似试验
已完成
不适用
Consideration of combination therapy with both vorinostat and ultraviolet therapy for cutaneous T-cell lymphoma patientsCutaneous T-cell lymphoma, Mycosis fungoides, Sezary's syndromeJPRN-UMIN000010590Department of Dermatology, Okayama University3
进行中（未招募）
不适用
T CELL DEPLETED HEMATOPOIETIC STEM CELL TRANSPLANT POST REDUCED INTENSITY CONDITIONING AND EARLY USE OF CYCLOPHOPHAMIDE-CLL patients with refractoriness to fludarabine or other chemotherapy due , Follicular lymphoma with either unfavourable cytogenetics such as complex karyotype, del17p, mutations in TP53, minus 1p- Hodgkin's Lymphoma relapsed after autologous transplantation, not elegible for immunotherapy with anti-CD30,-Multiple myeloma relapsing after autologous transplantation, with unfavourable cytogenetics in either partial or complete remissionMedDRA version: 17.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 17.0Level: LLTClassification code 10028567Term: Myeloma, malignantSystem Organ Class: 100000004864MedDRA version: 17.0Level: LLTClassification code 10024341Term: Leukemia lymphoidSystem Organ Class: 100000004864EUCTR2013-003628-35-ITAzienda Ospedaliero-Universitaria di Parma10
已完成
4 期
Three-armed study for therapy of primary and secondary syphilis in HIV infectioA53.9Syphilis, unspecifiedDRKS00000389St. Josef HospitalInterdisziplinäre Immunologische Ambulanz115
已完成
不适用
Effectiveness and mechanisms of a multimodal treatment for low back pain: a pragmatic matched cohort studyM54DorsalgiaDRKS00030389Bundesinstitut für Sportwissenschaft316
尚未招募
不适用
Comparison of triple therapy, sequential therapy, and concomitant quadruple therapy of Helicobacter pyloriDiseases of the digestive systemKCT0000703The Catholic University of Korea, Incheon St. Mary's Hospital510